Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 27 (11), 4250-8

Long-term Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer: A Single-Center Experience

Affiliations

Long-term Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer: A Single-Center Experience

Mun Ki Choi et al. Surg Endosc.

Abstract

Background: In Korea, endoscopic submucosal dissection (ESD) has been widely accepted for the treatment of early gastric cancers (EGCs). However, the understanding of the long-term clinical outcome of ESD for EGC remains insufficient. Therefore, the aim of the present study was to assess the long-term clinical outcome and efficacy of ESD for the treatment of EGCs, including the clinical application of the expanded criteria for ESD.

Methods: From January 2006 to December 2010, a total of 515 patients with 522 EGCs were treated by ESD in our hospital; study enrollment was based on the expanded criteria. Comparisons of resectability (en bloc or piecemeal resection), curability (curative or non-curative), and complications (bleeding and perforation) between the standard and expanded groups were assessed. Thereafter, 336 patients with 342 EGCs were finally included in a long-term analysis of local tumor recurrence, development of synchronous and metachronous cancers, and overall and disease-specific survival rates.

Results: En bloc and curative resection rates of 96.7 % and 88.3 %, respectively, were achieved. The curative resection rate was significantly lower in the expanded group than in the standard group (82.1 % vs. 91.5 %, p = 0.001). During a median follow-up of 24 months, the local tumor recurrence rate was also higher in the expanded group than in the standard group (7.0 % vs. 1.8 %, p = 0.025). Local recurrence was more frequent in lesions with non-curative resection than in those with curative resection (20.0 % vs. 1.3 %, p < 0.001). The 5-year overall and disease-specific survival rates were 88 % and 100 %, respectively; the difference between the standard and expanded groups was not significant (p = 0.834).

Conclusions: ESD appears to be a feasible and effective method for treating EGCs, based on the standard and expanded criteria. Close follow-up surveillance, after ESD, should be standard for all patients.

Similar articles

See all similar articles

Cited by 48 articles

See all "Cited by" articles

References

    1. Gut. 2009 Mar;58(3):331-6 - PubMed
    1. Gut. 2000 Nov;47(5):618-21 - PubMed
    1. J Clin Oncol. 2005 Jul 10;23(20):4490-8 - PubMed
    1. Surg Endosc. 2010 Nov;24(11):2842-9 - PubMed
    1. Endoscopy. 2009 Feb;41(2):118-22 - PubMed

Publication types

MeSH terms

LinkOut - more resources

Feedback